- £66.05bn
- £79.35bn
- £31.38bn
- 74
- 50
- 96
- 90
Annual balance sheet for GSK, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 6,370 | 4,335 | 7,877 | 4,992 | 3,714 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7,264 | 8,031 | 7,115 | 7,403 | 6,935 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 20,247 | 18,674 | 20,769 | 18,644 | 16,997 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11,006 | 10,672 | 9,620 | 9,957 | 10,073 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 80,431 | 79,103 | 60,146 | 59,005 | 59,463 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 22,148 | 23,670 | 22,810 | 21,068 | 21,697 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 65,844 | 64,048 | 49,548 | 45,658 | 45,792 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 14,587 | 15,055 | 10,598 | 13,347 | 13,671 |
| Total Liabilities & Shareholders' Equity | 80,431 | 79,103 | 60,146 | 59,005 | 59,463 |
| Total Common Shares Outstanding |